Emerging toxicities associated with ADCs

Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Korea, discusses the use of antibody-drug conjugates in breast cancer, highlighting associated toxicites such as neutropenia and interstitial lung disease, and how these can be managed to improve patient outcomes. This interview took place at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.